首页> 外国专利> CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES

CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES

机译：基于细胞的成分及其在糖尿病和相关代谢紊乱的治疗中的用途以及减轻糖尿病前期胰岛素抵抗的方法

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.

机译：本发明涉及基于细胞的组合物，其包含间充质干细胞在晶体中的悬浮液，其细胞浓度为0.01百万至3.0百万细胞/ ml。基于细胞的组合物以药物的形式用于治疗糖尿病及其相关的代谢紊乱和并发症。

著录项

公开/公告号US2017340676A1

专利类型
公开/公告日2017-11-30

原文格式PDF
申请/专利权人 CYTOPEUTICS SDN. BHD.;
展开▼

申请/专利号US201715597725
发明设计人 BERNARD SZE PIAW CHIN;KONG YONG THEN;SOON KENG CHEONG;
展开▼

申请日2017-05-17
分类号A61K35/28;A61K9;
国家 US
入库时间 2022-08-21 13:00:38

相似文献

专利
外文文献
中文文献